ORLANDO, Fla.--(BUSINESS WIRE)--The LGL Group, Inc. (“LGL” or “the Company”) announced today that its board of directors has authorized the company’s management team to explore a potential spin-off of ...
ORLANDO, Fla.--(BUSINESS WIRE)--The LGL Group, Inc. (NYSE American: LGL) (the “Company” or “LGL”) today announced that its previously announced spin-off of M-tron Industries, Inc. (“Mtron”) is ...
LGL leukemia represents 2% to 5% of chronic lymphoproliferative disorders in North America and Europe and 5% to 6% in Asia. Recently, the incidence of LGL leukemia has been published from two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results